![]() |
市場調査レポート
心血管系関連の各種提携契約:契約条件・合意内容Global Cardiovascular Partnering 2012-2018: Deal trends, players and financials |
||||||
発行 | Current Partnering, a division of Wildwood Ventures Limited | 商品コード | 233135 | ||||
出版日 | ページ情報 | 英文 500+ Pages 納期: 即日から翌営業日 |
|||||
価格 |
|
心血管系関連の各種提携契約:契約条件・合意内容 Global Cardiovascular Partnering 2012-2018: Deal trends, players and financials | ||
出版日: 2018年03月01日 | ページ情報: 英文 500+ Pages |
|
当レポートでは、心血管系関連の各種提携契約について調査分析し、近年における各種契約の動向、大規模契約および大手製薬会社による契約の概要、契約区分・開発ステージ・技術区分・適応症区分別のディレクトリなどをまとめ、概略下記の構成でお届けいたします。
Global Cardiovascular Partnering 2012-2018: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the cardiovascular partnering deals and agreements entered into by the worlds leading healthcare companies
Global Cardiovascular Partnering 2012 to 2018 provides the full collection of Cardiovascular disease deals signed between the world's pharmaceutical and biotechnology companies since 2012.
Trends in Cardiovascular partnering deals
Financial deal terms for headline, upfront and royalty by stage of development
Cardiovascular partnering agreement structure
Cardiovascular partnering contract documents
Top Cardiovascular deals by value
Most active Cardiovascular dealmakers
Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.
The report takes readers through the comprehensive Cardiovascular disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Cardiovascular deals.
The report presents financial deal terms values for Cardiovascular deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.
The initial chapters of this report provide an orientation of Cardiovascular dealmaking trends.
Chapter 1 provides an introduction to the report.
Chapter 2 provides an overview of the trends in Cardiovascular dealmaking since 2012 covering trends by year, deal type, stage of development, technology type and therapeutic indication.
Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.
Chapter 4 provides a review of the leading Cardiovascular deals since 2012. Deals are listed by headline value. The chapter includes the top 25 most active Cardiovascular dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
Chapter 5 provides comprehensive access to Cardiovascular deals since 2012 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.
Chapter 6 provides a comprehensive directory of all Cardiovascular partnering deals by specific Cardiovascular target announced since 2012. The chapter is organized by specific Cardiovascular therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
In addition, a comprehensive appendix is provided with each report of all Cardiovascular partnering deals signed and announced since 2012. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
The report also includes numerous tables and figures that illustrate the trends and activities in Cardiovascular partnering and dealmaking since 2012.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Cardiovascular technologies and products.
Global Cardiovascular Partnering 2012-2018: Deal trends, players and financials is intended to provide the reader with an in-depth understanding and access to cardiovascular trends and structure of deals entered into by leading companies worldwide.
Global Cardiovascular Partnering 2012-2018: Deal trends, players and financials includes:
In Global Cardiovascular Partnering 2012-2018: Deal trends, players and financials, the available deals are listed by:
The Global Cardiovascular Partnering 2012-2018: Deal trends, players and financials report provides comprehensive access to available deals and contract documents for over 1,000 cardiovascular deals. Analyzing actual contract agreements allows assessment of the following:
Global Cardiovascular Partnering 2012 to 2018 provides the reader with the following key benefits: